You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Denmark

Mar 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

OTC sales record modest growth in 2011

Value sales of consumer health increased slightly in Denmark in 2011. In comparison to 2010, the market registered a stronger growth rate. With the more favourable economic context, demand was in general slightly higher. Even though consumer health products continued to be necessities, safety concerns and a downward price trend were the key factors preventing a stronger value growth in OTC sales. Experts’ warnings raised consumers’ concern about the side effects and potential risks of taking certain products such as calming and sleeping, NRT smoking cessation aids and vitamins and dietary supplements. Categories regarded as necessities, such as digestive remedies, analgesics or cough, cold and allergy (hay fever) remedies maintained value growth in 2011.

Consumer concerns and decreasing unit prices stagnate value growth

Physicians and nutrition experts have been increasingly warning Danish consumers about the dangers of overuse, the possible side effects and the possibility of dependency when taking vitamins, herbal/traditional products and NRT smoking cessation aids. Furthermore, the National Food Institute also suggested that it is not necessary for adolescents to take dietary supplements as most people can get the necessary vitamins and minerals through a healthy diet. Thus unfavourable views from the authorities and experts made consumers think twice before purchasing these products. This, together with the decreasing average unit prices, was the key factor behind the slowdown in value growth of consumer health products. The development of private label, cheaper generic products and expanding distribution affected unit prices in a downwards trajectory.

Increasing concentration in competitive environment

Sales of consumer health products are increasingly characterised by consolidation. Numerous consumer health categories are dominated by a handful of players. Indeed major players are not just confined to one area of consumer health but have an overall presence across the spectrum of total consumer health sales. The top three players in consumer health in Denmark are multinationals McNeil, Nycomed and Novartis Healthcare that together account for one-third of consumer health sales in Denmark.

Chemists/pharmacies continues to be the most common outlet for consumer health products

Chemists/pharmacies continue to be the leading outlet channel for consumer health sales. Yet despite the fact that this channel accounts for the majority of consumer health sales, it is losing its foothold as other outlet channels, such as parapharmacies/drugstores, discounters and internet retailing, are gaining in importance. A significant amount of NRT cessation aids, vitamins and dietary supplements, sports nutrition, wound care and weight management products are purchased through other channels, such as grocery retailers and through internet retailing. This is due to convenience, as consumers find it convenient to shop for their healthcare products whilst doing their grocery shopping.

Stagnant sales predicted for the forecast period

Sales of consumer health are expected to record a minimal constant value CAGR over the forecast period. Growth will remain driven by similar factors as in the review period including the health and wellness trend, self-medication, an ageing Danish population and increased product segmentation. Market maturity, increased competition from private label and cheaper generic and parallel imports will remain the most significant challenge to value sales in consumer health.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Denmark with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Denmark, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Denmark for free:

The Consumer Health in Denmark market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Denmark?
  • What are the major brands in Denmark?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Denmark - Industry Overview

EXECUTIVE SUMMARY

OTC sales record modest growth in 2011

Consumer concerns and decreasing unit prices stagnate value growth

Increasing concentration in competitive environment

Chemists/pharmacies continues to be the most common outlet for consumer health products

Stagnant sales predicted for the forecast period

KEY TRENDS AND DEVELOPMENTS

Demographic changes shape demand for consumer health products

Self-medication is one of the drivers of sales

Market maturity slows down the growth rates

Distribution channels in heavy competition with each other

Online presence expands in consumer health

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011
  • Summary 2 Research Sources

Consumer Health in Denmark - Company Profiles

Actavis Nordic A/S in Consumer Health (Denmark)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Actavis Nordic A/S: Competitive Position 2011

Axellus A/S in Consumer Health (Denmark)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Axellus A/S: Competitive Position 2011

Ferrosan A/S in Consumer Health (Denmark)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Ferrosan A/S: Competitive Position 2011

Nycomed Danmark A/S in Consumer Health (Denmark)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Nycomed Danmark A/S: Competitive Position 2011

Orifarm A/S in Consumer Health (Denmark)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Orifarm A/S: Competitive Position 2011

Adult Mouth Care in Denmark - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care declined by 1% in 2011 to reach sales of DKr22 million. The decline was mainly because the category faced strong competition from widely available traditional oral care products. In fact, improvements in traditional oral care products such as toothpaste, mouthwashes and dental rinses subsequently undermined demand for adult mouth care. Most Danish consumers find standard oral care products to be sufficient. For treating more serious mouth problems, such as gum infections, many consumers seek professional advice and obtain a prescription, rather than self medicating with OTC products. Furthermore, OTC adult mouth care does not have the same level of marketing and advertising compared to standard oral care products, resulting in continued decline in sales of adult mouth care.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil led sales of adult mouth care with a current value share of 32% in 2011. This position was due to its brand Hextril, an antiseptic mouthwash for disinfection and cleaning of the mouth and throat. Hextril comes in mouthwash format for disinfection and cleaning of the mouth and throat with two products: Hextril and Hextril Mint. The brand gradually gained value share over the review period and won consumer credibility. It increased by almost one percentage point in 2011 to further strengthen its position in adult mouth care in Denmark.

PROSPECTS

  • Adult mouth care is projected to record a contracting CAGR of 2% in constant value terms over the 2011-2016 forecast period to reach DKr20 million. The low consumer demand for adult mouth care products is unlikely to change in the forecast period, thus growth rates will remain low. The main reasons behind the low growth will be maturity of the category, little activity from manufacturers and increasing competition from standard oral care products.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Denmark - Category Analysis

HEADLINES

TRENDS

  • In 2011 sales of analgesics increased by 1% in current terms to reach DKr535 million. Growth in sales was driven mainly by increased use of analgesics as well as the ageing population. According to the Lægemiddelstyrelsen (Danish Medicines Agency), the main growth did not come from over-the-counter sales, which in the 1996-2010 period increased by only 1%, but from the increased sales of these OTC drugs on prescription. Furthermore, many consumers use analgesics to cope with stress-related illnesses such as headaches and stomach aches. Hectic lifestyles are among the reasons for stress and research carried out by the National Institute of Public Health at Southern University and the Faculty of Pharmaceutical Sciences at the University shows that young consumers aged 25-44 are the most affected by stress. They are also the ones who consume the most OTC medicine for treatment of pain.

SWITCHES

COMPETITIVE LANDSCAPE

  • The analgesics category in Denmark is very concentrated as the three top companies - Nycomed, GlaxoSmithKline and Actavis - dominate accounting for 79% of analgesics sales in 2011. All three companies hold several of the most popular brands. Furthermore, the concentration is mainly due to restricted distribution of analgesics as sales are largely undertaken through chemists/pharmacies, which accounts for 98% of distribution.

PROSPECTS

  • Analgesics is expected to grow by a CAGR of 1% in constant value terms over 2011-2016 to reach DKr550 million in 2016. The growing ageing population and increasing stress-related health problems will be the key factors behind the growth of analgesics over the forecast period. Furthermore, liberalisation of consumer health and the self-medication trend will continue to have a positive impact on growth rates throughout the forecast period. However, the implementation of new rules on sales of painkillers that restrict the age of consumers able to buy them will result in more sales of OTC analgesics.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Denmark - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products recorded a 3% current value decline in 2011. Although insomnia and stress related illnesses are very common in Denmark, sales of calming and sleeping products have suffered from increasing warnings related to the side effects of using herbal calming and sleeping products such as valerian. Warnings about the negative side effects of herbal products, especially to the liver, became increasingly common throughout the review period. This made consumers more reluctant to seek calming and sleeping products for self medication, as the majority of OTC calming and sleeping medicines are herbal/traditional products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Axellus maintained its leading position with a value share of 20% in 2011. It held this position through its leading brand Drogen’s Baldrian B+. Drogen’s Baldrian B+ is made of valerian and lemon myrtle and is suitable for treating anxiety and insomnia. It is a well-known and well-established brand on the Danish market and benefits from high consumer trust.

PROSPECTS

  • Calming and sleeping products is expected to record a contracting CAGR of 4% in constant value terms over the 2011-2016 forecast period. The negative trend of the review period is unlikely to be reversed and calming and sleeping products are unlikely to gain more consumer confidence over the forecast period. Furthermore, increasing price competition due to widening distribution and a growing popularity of private label will have a negative impact on value sales’ growth. However, demand for calming and sleeping products will remain in place, albeit low. It will be driven by busy lifestyles causing stress and lack of sleep. Furthermore, the growing elderly population, which is also now more prone to sleep problems, will contribute to the demand.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Denmark - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies grow by 3% in current terms to reach sales of DKr531 million in 2011. Sales were driven by growing numbers of people suffering from coughs and colds and increased numbers of allergy cases. However, the winter of 2011 was significantly milder than that in 2010 which resulted in slightly lower demand for cough and cold remedies. Furthermore, marketing and widening distribution were key factors driving value growth of cough, cold and allergy (hay fever) remedies in 2011. Manufacturers particularly invested in promoting medicated confectionery such as Halls, nasal sprays such as Otrivin and Zymelin and pharyngeal preparations, including Strepsils. Widely distributed not only via pharmacies but also grocery retailers, convenience stores and forecourt retailers, these brands were very visible and easily available to consumers, offering convenience and instant relief for cough and cold symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Healthcare led the sales of cough, cold and allergy (hay fever) remedies with a value share of 20% in 2011. The company held this position through its strong brands Strepsils and Otrivin. Novartis was the leading player in pharyngeal preparations with its Strepsils brand which held a 77% value share via sales of DKr52 million. Otrivin is the leader in decongestants accounting for 47% of that category. These brands are all heavily marketed and amongst the most widely distributed OTC brands.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to grow by a CAGR of 1% in constant value terms over the forecast period. The basic demand for cold and allergy (hay fever) remedies is expected to remain rather stable throughout the forecast period. Although the category is no longer young, some less mature and more dynamic categories will continue to push sales, such as nasal decongestants. However, the category will have to fight against more affordable generics, which may hinder value sales growth. Nonetheless, consumers are expected to react well to intense advertising campaigns, as well as to invest in efficient cough, cold and allergy remedies. Thus marketing and convenience are expected to remain the key positive growth drivers in cough and cold remedies.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 37 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Denmark - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies recorded 1% current value growth in 2011 to reach sales of DKr358 million. Busy lifestyles meant increased numbers of people suffering from stress-related problems, which in turn resulted in growing sales of proton pump inhibitors, for instance. The ageing population has been another driver of category sales. Ageing can lead to difficulties in digesting food, thus acidity, heartburn and constipation continue to offer good opportunities for growth of digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil, a subsidiary of Johnson & Johnson, led sales of digestive remedies with a current value share of 15% in 2011. Its most successful brand Imodium held 5% of total digestive remedies’ sales and was the key brand in diarrhoeal remedies accounting for 33% of that category. Imodium Plus was the second largest brand in diarrhoeal remedies with a current value share of 24%. Together both brands accounted for combined sales of DKr31 million. Imodium and Imodium Plus were the most widely distributed digestive remedies in the Danish market. Widening distribution and TV advertisements for these two brands underpinned the steady sales growth of the company.

PROSPECTS

  • With the exception of the emerging proton pump inhibitors category, digestive remedies is mature and sales are expected to continue to grow moderately by a CAGR of 1% in constant value terms over the forecast period. Growth is expected to be driven by greater availability of foods that cause constipation and indigestion, as well as busy lifestyles and stress, the ageing population and increasing advertising and awareness of the benefits of digestive remedies.

CATEGORY DATA

  • Table 39 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 40 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 41 Digestive Remedies Company Shares by Value 2007-2011
  • Table 42 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 43 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 44 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Denmark - Category Analysis

HEADLINES

TRENDS

  • Despite the interest in good health, ear care remains a marginal category. OTC ear care products are usually limited to ear drops to keep the ear canals clear from ear wax and there are only a few brands of such products available. Only a limited number of consumers feel the need to purchase these products. More serious problems with ear infections are treated with Rx medication. Products to treat more serious ear infections are not available as OTC medicines, which meant that more acute health issues have to be solved through a doctor.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion Pharma continued to lead ear care sales in 2011 with a current value share of 68%. This position was thanks to the Remo-Wax brand. The brand has been on the Danish market since 1970. Benefiting from its long history in the market, Remo-Wax won the majority of users’ trust. Medic Team held a 26% value share and ranked second through its Glycerol Øredråber.

PROSPECTS

  • Sales of ear care are expected to grow by a CAGR of 1% in constant value terms over the 2011-2016 forecast period to reach DKr15 million in 2016. Due to the small product selection and slowly growing customer base, ear care will face stagnation. Lack of product innovation and marketing investment will also impact the sales in a downwards direction.

CATEGORY DATA

  • Table 45 Sales of Ear Care: Value 2006-2011
  • Table 46 Sales of Ear Care: % Value Growth 2006-2011
  • Table 47 Ear Care Company Shares by Value 2007-2011
  • Table 48 Ear Care Brand Shares by Value 2008-2011
  • Table 49 Forecast Sales of Ear Care: Value 2011-2016
  • Table 50 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Denmark - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception grew by 2% in current terms to reach sales of DKr11 million in 2011. Casual attitudes to sexual intercourse was one of the factors supporting the demand for emergency contraception. These attitudes are perhaps linked to consumers’ lack of concern about the transmission of sexual diseases. Furthermore, a general factor supporting category demand is the growing trend towards self-medication.

COMPETITIVE LANDSCAPE

  • Nycomed led in emergency contraception sales with a current value share of 84% in 2011. The company is the national brand owner of the leading emergency contraception brand NorLevo. NorLevo was the first emergency contraception brand to be available in Denmark and therefore gained from a first-mover advantage. Sales of emergency contraception are by law restricted to chemists/pharmacies, and Nycomed holds very strong distribution contracts within this channel. NorLevo by Nycomed witnessed a sales increase in 2011, yet its market share remained pretty much unchanged from the previous year.

PROSPECTS

  • Emergency contraception is expected to grow by a 1% constant value CAGR in 2011-2016 to reach DKr12 million in 2016. Women are expected to continue purchasing the product not only for immediate use, but also to be stored for an emergency at home. Furthermore, similarly to the review period, casual attitudes to sexual intercourse will ensure continued demand for emergency contraception in the forecast period. Consumer willingness to self-medicate will also support this demand.

CATEGORY DATA

  • Table 51 Sales of Emergency Contraception: Value 2006-2011
  • Table 52 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 53 Emergency Contraception Company Shares by Value 2007-2011
  • Table 54 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 55 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 56 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Denmark - Category Analysis

HEADLINES

TRENDS

  • Eye care increased by 1% in current terms to reach DKr68 million in 2011. Growth was mainly due to the increasing occurrence of dry eye symptoms and allergies mainly caused by modern lifestyles. People spend more time indoors in front of TVs or computer screens, and use air conditioning and central heating. Growing use of contact lenses also contributed to growth. The growing population aged 65+ was another factor behind the increase in eye care sales. Glaucoma is a common eye disease in the ageing population. Since 1970, more than 1% of the adult Danish population had chronic open-angle glaucoma and needed to have eye care treatments. Furthermore, eye care products were often advertised, drawing consumers’ attention to product availability.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Healthcare led eye care sales with a value share of 35% in 2011. Novartis Healthcare’s lead was a result of its popular Viscotears brand, but the company also has a number of other smaller brands in its portfolio, such as Oculac, Antistina-Privin and Zaditen. These brands offer a good selection of products, which are also well advertised and benefit from good nationwide distribution.

PROSPECTS

  • Eye care is forecast to grow by a CAGR of 1% in constant value terms over the forecast period to reach DKr71 million in 2016. Allergy levels are expected to increase, which will boost sales of allergy eye care products. These are especially in demand in the spring. Incidences of dry eyes, caused by the use of contact lenses, longer time spent in front of computers or TVs, are also expected to become increasingly frequent. Thus standard eye care sales are expected to grow. Furthermore, the growing population aged over 65will also boost the sales.

CATEGORY DATA

  • Table 57 Sales of Eye Care by Category: Value 2006-2011
  • Table 58 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 59 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 60 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 61 Eye Care Company Shares by Value 2007-2011
  • Table 62 Eye Care Brand Shares by Value 2008-2011
  • Table 63 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Denmark - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products recorded a 1% decrease in 2011 taking sales to DKr436 million. The decline was mainly due to negative publicity herbal/traditional products received towards the end of the review period. Danish consumers were increasingly warned about the possible side effects of such products. Liver specialists warned of an increasing number of reported cases of serious liver damage due to herbal remedies and dietary supplements. Cardiologists also warned that some herbal/traditional products can cause dangerous side effects and risks for patients who are already taking traditional medicines. Thus worries about the safety of using herbal/traditional products negatively affected value sales.

COMPETITIVE LANDSCAPE

  • The competitive environment for herbal/traditional products in Denmark is rather fragmented. Apart from the market leaders Cadbury Stimorol and Axellus, herbal/traditional product sales are characterised by many players, all with value shares of under 10%. These players differ widely in terms of their product assortment and choice of distribution channel.

PROSPECTS

  • Herbal/traditional products are predicted to record a declining CAGR of 1% over 2011-2016 to reach sales of DKK410 million. Consumer scepticism and an unfavourable perception among doctors and experts will remain the main reasons behind the decline of herbal/traditional products. The medical establishment in Denmark is unlikely to change its attitude since it is heavily involved with the pharmaceuticals industry, and will thus continue to favour standard OTC and prescription medicines over herbal/traditional products. Furthermore, as distribution expands and non-specialist channels, such as grocery retailers, parapharmacies/drugstores and internet retailing become increasingly important, price competition among different channels is expected to increase, which in turn will slow down value sales growth.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 67 Herbal/Traditional Products Company Shares 2007-2011
  • Table 68 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Denmark - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and cure their skin problems independently, rather than visit a doctor. Some consumers are time-constrained whilst others might feel embarrassed about their particular skin condition. Vaginal antifungals, hair loss treatments, antiparasitics/lice (head and body) treatments and cold sore treatments are skin conditions that most sufferers prefer to keep to themselves. However, the medicated skin care category is already mature, thus growth rates are rather modest. Furthermore, average unit prices are showing a downwards trend thereby slowing value sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil led the sales of medicated skin care with a current value share of 12% in 2011. McNeil achieved this position through its leading brands Brentan, Nizoral and Regaine Forte. Brentan had an 18% value share in topical antifungals and witnessed a steady increase in its share throughout the review period. Nizoral accounted for a significantly lower share of 3% in topical antifungals . Yet its share also rose during the review period. Regaine Forte was the leading brand in hair loss treatments accounting for 79% of total value sales, while Regaine was the only other brand in the category holding the remaining 21%. McNeil was one of the few companies to see its sales increase in 2011. However, its market share decreased slightly as the total medicated skin care market contracted.

PROSPECTS

  • Medicated skin care is predicted to see a negligible positive constant value CAGR over the forecast period. The category is already mature and companies will have to deal with saturation. Furthermore, the competition in many categories is strong due to a wide selection of brands and presence of generic products, which push the average unit price down, and thus also slows down the growth of value sales. Generic and private label are expected to continue to interest consumers due to their lower prices. Growth, yet marginal, will come from an increasing number of allergy cases and partly from the ageing population.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 73 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 74 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 75 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 76 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 77 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Denmark - Category Analysis

HEADLINES

TRENDS

  • Social acceptance of smoking and legislation has become less tolerant towards smoking in Denmark. An increasing number of restrictions prohibit smoking in public places and governments are funding major public health campaigns that make the dangers of smoking clear. Danish consumers are also very concerned about their general wellbeing, leading many people to give up smoking. In fact, the number of smokers declined throughout the review period, dropping by 1% alone in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil leads the sales of NRT smoking cessation aids with a current value share of 51% in 2011. McNeil produces and markets the Nicorette brands of chewing gum, inhalators, micro tabs and patches. In 2011 McNeil’s sales decreased slightly although the company maintained its value share and leading position, as the overall market size of NRT smoking cessation aids also contracted.

PROSPECTS

  • NRT smoking cessation aids is forecast to record a declining 1% constant value CAGR over 2011-2016 to reach sales of DKr282 million in 2016. Increasing social pressure and antipathy towards smokers, legislation becoming more intolerant of tobacco products, stronger campaigns and increasing health and wellbeing concerns are expected to encourage consumers to quit smoking. In fact Euromonitor International predicts that over the forecast period the total number of smokers will decline by another 3%. However, not all consumers who quit smoking will turn to NRT smoking cessation aids for help. Consumers are likely to opt for will power to quit smoking. Thus as seen over the review period, the growing concern about addiction to NRT smoking cessation aids will be the key factor stagnating the growth.

CATEGORY INDICATORS

  • Table 78 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 79 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 80 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 81 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 82 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 83 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Denmark - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition recorded growth of 1% reaching sales of DKr116 million in 2011. The health and wellness trend is among the key drivers of value growth when it comes to many product categories in Denmark, such as packaged food or vitamins and dietary supplements. This trend was especially important in sports nutrition sales as it boosted the popularity of the fitness culture in Denmark, which in return benefited from growing gym memberships. The media’s focus on healthy lifestyles and growing public obsession with beauty is pushing many consumers to take care of their health. The need to counter sedentary lifestyles through sport is increasingly taking a central role in the Danish health debate within the mainstream media. Manufacturers of sports nutrition responded successfully to the trend and offered consumers a wide variety of products to reach their goals, be it body building or recovery after exercising.

COMPETITIVE LANDSCAPE

  • Sports nutrition sales in Denmark are rather concentrated. Sales witnessed a degree of consolidation over the review period with the bulk of sales increasingly concentrated between a relatively small number of players. The Danish competitive environment is dominated by three players: Maxim Danmark, Bodylab Nutrition and Nutramino. Maxim and Nutramino both have a strong presence in sales from fitness centres. Their main source of sales growth is, however, through widening distribution into grocery retailers. Bodylab Nutrition distributes entirely through internet retailing.

PROSPECTS

  • Sports nutrition is expected to record a 1% constant value CAGR in 2011-2016 to reach sales of DKr119 million in 2016. Consumer interest in using sports clubs is expected to remain strong, along with an increasing interest in achieving optimal results. Furthermore, people are becoming more educated about sports nutrition products, through magazines and internet sites. These factors will lead to growth in sales during the forecast period. However, sales will remain limited to a small consumer group of consumers who have a strong interest in fitness and wellbeing and exercise more frequently than the average person. They are also the consumers who have better knowledge of sports nutrition products. Furthermore, marketing and advertising will remain one of the key drivers of value over the forecast period.

CATEGORY DATA

  • Table 86 Sales of Sports Nutrition: Value 2006-2011
  • Table 87 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 88 Sports Nutrition Company Shares 2007-2011
  • Table 89 Sports Nutrition Brand Shares 2008-2011
  • Table 90 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 91 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Denmark - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements grew by 1% in current terms in 2011 to reach sales of DKr961 million. Consumer health awareness is at an all time high which is encouraging the strong growth of the category. Innovations and new product developments are also facilitating this growth by helping to broaden the appeal of the category. The growth rates, however, were hampered by slow economic recovery and a rising unemployment rate, which affected vitamins and dietary supplements more than other OTC medicine categories since vitamins and dietary supplements are not regarded as an essential product group. Furthermore, manufacturers’ price discounting of vitamins and dietary supplements partially offset value sales growth.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Domestic manufacturers such as Axellus, Ferrosan, Matas and Mezina led sales of vitamins and dietary supplements. Sales of vitamins and dietary supplements in Denmark are rather concentrated as the four companies held a combined value share of 49% in 2011. Nonetheless, Danish consumers have no particular local preferences when it comes to vitamins and dietary supplements and as in most other Western European countries, multivitamins, fish oils and calcium and mineral supplements are the most popular vitamins and dietary supplements products.

PROSPECTS

  • Vitamins and dietary supplements is expected to record a 1% constant value CAGR over the forecast period. Growth will come from the health trend and growing interest in self-medication and preventative medicine, new launches and advertising campaigns. Other factors underpinning demand will include an ageing population, as well as the increasing occurrence of lifestyle-related illnesses, and the fact that both work and social lives are becoming more demanding. However, increasing growing consumer concerns about the side effects will lower demand for vitamins and dietary supplements. As distribution through grocery retailers and internet retailing is expected to continue expanding over the forecast period, this will drive unit prices and value growth downwards.

CATEGORY DATA

  • Table 92 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 93 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 94 Dietary Supplements by Positioning 2006-2011
  • Table 95 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 96 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 97 Vitamins Brand Shares by Value 2008-2011
  • Table 98 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 100 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 18 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Denmark - Category Analysis

HEADLINES

TRENDS

  • Danish consumers are bombarded with messages about the importance of healthy living from the media and official authorities. Institutions, such as Fødevarestyrelsen (Ministry of Food, Agriculture and Fisheries) are constantly educating people on healthy diets based on fruit, vegetables, grains and protein, and the importance of exercising. Thus the pursuit of a healthy and fit body is the main reason behind the growth of weight management product sales. Driven by the health and wellness trend, sales of weight management grew by 3% to reach DKr155 million in 2011.

COMPETITIVE LANDSCAPE

  • The competitive environment for weight management is characterised by diversity. Three companies, Nupo, Herbalife and GlaxoSmithKline lead weight management with respective value shares of 38%, 19% and 15% in 2011. The remaining value share is apportioned among other smaller players, often with portfolios of only a few products. Nupo is a local company working with domestically developed products, while Herbalife and GlaxoSmithKline are strong international players.

PROSPECTS

  • Preoccupation with weight and obesity concerns will remain the key driver of category sales. Weight management is expected to record a 2% constant value CAGR in the 2011-2016 forecast period and to reach sales of DKr168 million by 2016. Increased body-consciousness, less time for exercise and strong advertising will help to push value sales. Consumers are also attracted to the idea that weight management products offer a “quick fix” in order to lose a few kilos more easily and even faster.

CATEGORY DATA

  • Table 101 Sales of Weight Management: Value 2006-2011
  • Table 102 Sales of Weight Management: % Value Growth 2006-2011
  • Table 103 Weight Management Brand Shares 2008-2011
  • Table 104 Forecast Sales of Weight Management: Value 2011-2016
  • Table 105 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Denmark - Category Analysis

HEADLINES

TRENDS

  • Wound care increased by 1% in current terms in 2011. The negative economic climate was one of the reasons behind this moderate performance of wound care. Wound care products are present in virtually all households, as consumers stock them up for emergencies. When the economic situation worsened, consumers bought less wound care and used the reserve stocks they had at home. Furthermore, the wound care category is very mature and has high penetration levels, thus strong growth rates can hardly be expected. Thus innovation and segmentation are very important in pushing sales in this category. To attract consumer attention companies developed wound care products specifically designed for different functions and target groups, such as wound care for toes, blisters, knees, children and people active in sports.

COMPETITIVE LANDSCAPE

  • McNeil led sales of wound care in Denmark with a current value share of 23% in 2011. Its leadership came through the bestselling brand Compeed, that offers a wide range of plasters aimed to help and treat different conditions such as blisters, cold sores, dry and cracked skin, finger lacerations and many others. The Compeed brand accounted for 23% of total wound care value sales and 27% of total sales of sticking plasters/adhesive bandages.

PROSPECTS

  • Wound care sales are expected to record a CAGR of 1% in constant value terms over the forecast period to reach DKr73million by 2016. As wound care is a mature category with high penetration, slow growth is to be expected. New product developments are expected to be the key sales drivers with companies likely to focus on launching more sophisticated and segmented products that offer benefits in terms of healing faster, removing pain, disinfecting wounds and making wounded areas appear more attractive. If the economic climate improves faster than expected during the review period, the forecast CAGR could exceed 1%, as consumers will opt for higher priced premium wound care options more often.

CATEGORY DATA

  • Table 106 Sales of Wound Care by Category: Value 2006-2011
  • Table 107 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 108 Wound Care Company Shares by Value 2007-2011
  • Table 109 Wound Care Brand Shares by Value 2008-2011
  • Table 110 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 111 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Chlorella
            • Cranberry
            • Ginger
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Chromium
            • Propolis
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!